Haleon’s Sales Dragged Down by a Weak Cold and Flu Season

Haleon Plc’s first quarter was weaker than expected, hurt by lackluster demand for its over-the-counter cold and flu medicines.

Sales overall rose 2.2% in the first quarter, the maker of Panadol and Advil painkillers said Wednesday, less than the 2.4% expected by analysts.